{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:12:29Z","timestamp":1771956749437,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12094-012-0774-6","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T14:49:15Z","timestamp":1329403755000},"page":"143-149","source":"Crossref","is-referenced-by-count":40,"title":["JAK\/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"14","author":[{"given":"Zhenbing","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,17]]},"reference":[{"key":"774_CR1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1442-2050.2009.01043.x","volume":"23","author":"H. Jiang","year":"2010","unstructured":"Jiang H, Gong M, Cui Y et al (2010) Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China. Dis Esophagus 23:487\u2013492","journal-title":"Dis Esophagus"},{"key":"774_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1442-2050.2009.01035.x","volume":"23","author":"W.S. Wang","year":"2010","unstructured":"Wang WS, Zhong HJ, Xiao DW et al (2010) The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Dis Esophagus 23:512\u2013521","journal-title":"Dis Esophagus"},{"key":"774_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10517-009-0659-z","volume":"148","author":"V.V. Delektorskaya","year":"2009","unstructured":"Delektorskaya VV, Chemeris GY, Kononets PV et al (2009) Clinical significance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma. Bull Exp Biol Med 148:241\u2013245","journal-title":"Bull Exp Biol Med"},{"key":"774_CR4","first-page":"3375","volume":"29","author":"A. Sano","year":"2009","unstructured":"Sano A, Sakurai S, Kato H et al (2009) Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma. Anticancer Res 29:3375\u20133380","journal-title":"Anticancer Res"},{"key":"774_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000101894","volume":"24","author":"H. Kato","year":"2007","unstructured":"Kato H, Fukuchi M, Miyazaki T (2007) Surgical treatment for esophageal cancer. Current issues. Dig Surg 24:88\u201395","journal-title":"Dig Surg"},{"key":"774_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1050-1738(02)00230-X","volume":"13","author":"R. Bolli","year":"2003","unstructured":"Bolli R, Dawn B, Xuan YT (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia\/reperfusion injury. Trends Cardiovasc Med 13:72\u201379","journal-title":"Trends Cardiovasc Med"},{"key":"774_CR7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1006\/jmcc.2002.2076","volume":"34","author":"G.W. Booz","year":"2002","unstructured":"Booz GW, Day JN, Baker KM (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia\/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34:1443\u20131453","journal-title":"J Mol Cell Cardiol"},{"key":"774_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/ajpheart.00003.2006","volume":"291","author":"E.R. Gross","year":"2006","unstructured":"Gross ER, Hsu AK, Gross GJ (2006) The JAK\/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT-3, Akt, and GSK-3\u00df. Am J Physiol Heart Circ Physiol 291:827\u2013834","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"774_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.regpep.2009.09.001","volume":"159","author":"U. Kandalam","year":"2010","unstructured":"Kandalam U, Clark MA (2010) Angiotensin II activates JAK2\/STAT-3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes. Regul Pept 159:110\u2013116","journal-title":"Regul Pept"},{"key":"774_CR10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"J.E. Darnell Jr","year":"1997","unstructured":"Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630\u20131635","journal-title":"Science"},{"key":"774_CR11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"D.E. Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651\u2013662","journal-title":"Nat Rev Mol Cell Biol"},{"key":"774_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","volume":"197","author":"V. Calo","year":"2003","unstructured":"Calo V, Migliavacca M, Bazan V (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157\u2013168","journal-title":"J Cell Physiol"},{"key":"774_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","volume":"23","author":"J.F. Bromberg","year":"2001","unstructured":"Bromberg JF (2001) Activation of STAT proteins and growth control. Bioessays 23:161\u2013169","journal-title":"Bioessays"},{"key":"774_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-437X(00)00119-2","volume":"10","author":"J.G. Williams","year":"2000","unstructured":"Williams JG (2000) STAT signaling in cell proliferation and in development. Curr Opin Genet Dev 10:503\u2013507","journal-title":"Curr Opin Genet Dev"},{"key":"774_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1096\/fj.01-0633fje","volume":"16","author":"D. Valdembri","year":"2002","unstructured":"Valdembri D, Serini G, Vacca A (2002) In vivo activation of JAK2\/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 16:225\u2013227","journal-title":"FASEB J"},{"key":"774_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12032-010-9435-1","volume":"28","author":"Y. Tu","year":"2011","unstructured":"Tu Y, Zhong Y, Fu J et al (2011) Activation of JAK\/STAT signal pathway predicts poor prognosis of patients with gliomas. Med Oncol 28:15\u201323","journal-title":"Med Oncol"},{"key":"774_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.bjc.6603871","volume":"97","author":"L. Tam","year":"2007","unstructured":"Tam L, McGlynn LM, Traynor P et al (2007) Expression levels of the JAK\/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. Br J Cancer 97:378\u2013383","journal-title":"Br J Cancer"},{"key":"774_CR18","volume-title":"World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system","author":"S. Hamilton","year":"2000","unstructured":"Hamilton S, Aaltonen L (2000) World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. IARC, Lyon"},{"key":"774_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(00)02430-3","volume":"488","author":"B. Gao","year":"2001","unstructured":"Gao B, Shen XN, Kunos G (2001) Constitutive activation of JAK-STAT-3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 488:179\u2013184","journal-title":"FEBS Lett"},{"key":"774_CR20","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/sj.onc.1203483","volume":"19","author":"J.I. Song","year":"2000","unstructured":"Song JI, Rubin Grandis J (2000) STAT signaling in head and neck cancer. Oncogene 19:2489\u20132495","journal-title":"Oncogene"},{"key":"774_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/gyno.2000.5931","volume":"79","author":"M. Huang","year":"2000","unstructured":"Huang M, Page C, Reynolds RK (2000) Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 79:67\u201373","journal-title":"Gynecol Oncol"},{"key":"774_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)63940-5","volume":"158","author":"C.L. Campbell","year":"2001","unstructured":"Campbell CL, Jiang Z, Savarese DM (2001) Increased expression of the interleukin-11 receptor and evidence of Stat3 activation in prostate carcinoma. Am J Pathol 158:25\u201332","journal-title":"Am J Pathol"},{"key":"774_CR23","first-page":"1155","volume":"19","author":"G. Berclaz","year":"2001","unstructured":"Berclaz G, Altermatt HJ, Rohrbach V (2001) EGFR dependent expression of Stat3 (but not STAT1) in breast cancer. Int J Oncol 19:1155\u20131160","journal-title":"Int J Oncol"},{"key":"774_CR24","first-page":"23","volume":"17","author":"C. Page","year":"2000","unstructured":"Page C, Huang M, Jin X (2000) Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells. Int J Oncol 17:23\u201328","journal-title":"Int J Oncol"},{"key":"774_CR25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","volume":"22","author":"L. Wei","year":"2003","unstructured":"Wei L, Kuo ML, Chen CA (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22:1517\u20131527","journal-title":"Oncogene"},{"key":"774_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.8.5.409","volume":"5","author":"J. Turkson","year":"2004","unstructured":"Turkson J (2004) STAT proteins as novel targets for cancer drug discovery. Exp Opin Ther Targets 5:409\u2013422","journal-title":"Exp Opin Ther Targets"},{"key":"774_CR27","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/MCB.18.5.2545","volume":"18","author":"J. Turkson","year":"1998","unstructured":"Turkson J, Tammy Bowman T, Garcia R et al (1998) Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18:2545\u20132552","journal-title":"Mol Cell Biol"},{"key":"774_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ncponc0195","volume":"2","author":"E.B. Haura","year":"2005","unstructured":"Haura EB, Turkson J, Jove R (2005) Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2:315\u2013324","journal-title":"Nat Clin Pract Oncol"},{"key":"774_CR29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","volume":"10","author":"T. Wang","year":"2004","unstructured":"Wang T, Niu G, Kortylewski M (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10:48\u201354","journal-title":"Nat Med"},{"key":"774_CR30","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","volume":"21","author":"G. Niu","year":"2002","unstructured":"Niu G, Wright KL, Huang M (2002) Constitutive STAT3 activity up-regulates VEGF expression in tumor angiogenesis. Oncogene 21:2000\u20132008","journal-title":"Oncogene"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0774-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0774-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0774-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T16:54:39Z","timestamp":1561308879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0774-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0774-6","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}